BIOMAT Database Logo BIOMAT Database Logo

Immunogenicity of recombinant yeast hepatitis B vaccine. 1985

M Davidson, and S Krugman

UI MeSH Term Description Entries
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014761 Viral Hepatitis Vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis. Hepatitis, Viral, Vaccines,Hepatitis Vaccines, Viral,Vaccines, Viral Hepatitis
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

M Davidson, and S Krugman
Immunogenicity of recombinant hepatitis B vaccine.
February 1985, Lancet (London, England),
M Davidson, and S Krugman
Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children.
April 1988, The New Zealand medical journal,
M Davidson, and S Krugman
Recombinant yeast hepatitis B vaccine.
January 1986, Developments in biological standardization,
M Davidson, and S Krugman
Yeast recombinant hepatitis B vaccine.
January 1987, Infection,
M Davidson, and S Krugman
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children.
January 1989, Journal of medical virology,
M Davidson, and S Krugman
[Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in adults].
November 2002, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
M Davidson, and S Krugman
Reactogenicity and immunogenicity of a new recombinant yeast-derived hepatitis B vaccine.
November 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
M Davidson, and S Krugman
[Hepatitis B recombinant vaccine. Tolerance and immunogenicity].
October 1985, Deutsche medizinische Wochenschrift (1946),
M Davidson, and S Krugman
Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine.
January 1990, Acta paediatrica Scandinavica,
M Davidson, and S Krugman
Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization.
March 1994, JAMA,
Copied contents to your clipboard!